Skip to main content

Main menu

  • About
    • Our Mission
    • Donors
    • Board of Directors
    • Advisory Boards
    • Staff
    • Careers
    • FAQ
    • Annual Report
  • Why New TB Drugs?
    • Global Pandemic
    • Inadequate Treatment
    • Antimicrobial Resistance
    • Maternal and Child Health
    • Cycle of Poverty
  • R&D
    • Scientific Vision
    • Pipeline
    • Discovery
    • Engaging Communities
  • Access
    • Our Commitment
    • Access in TB Market
    • Child-friendly medicines
    • Pretomanid and BPaL
    • Pathways to Access BPaL
  • News
    • Latest News
    • Publications
    • Voices of TB
    • Research Papers
    • Making an Impact
  • Donate

Search form

Latest News

March 10

Ratan P. Watal Appointed to the Board of TB Alliance

March 8

TB and Women, on International Women’s Day 2023

February 23

TB Alliance Announces David Norton as Board Chair

All News

Voices of TB

Videos from the Global Health Community

Besik's Story of #TBCourage

Fighting the Oldest Pandemic

All Voices

Featured Publication

Keeping The Promise

  • Click here to download the full report

All Publications

Research Papers

Extemporaneously compounded liquid formulations of clofazimine
Assessing adverse events in clinical trials during the era of the COVID-19 pandemic
Comparison of pharmacokinetics and bioavailability of bedaquiline fumarate, benzoate and maleate in dogs
All Papers

For the Press

Press Contact:
Thomas Lynch
p | +1 646 616 8639
e | thomas.lynch@tballiance.org

View the 2021 Annual Report

Navigate

  • About
  • Why New TB Drugs?
  • R&D
  • Access
  • News
  • Donate

New York: 80 Pine Street, 20th floor, New York, NY 10005 • +1 212 227 7540

Pretoria: Boardwalk Office Park, Block 1/Suite 5, 107 Haymeadow Street, Faerie Glen, Pretoria 0043, South Africa • +27 12 991 6328

Visit our South Africa website
Press Inquiries

Thomas Lynch
p | +1 646 616 8639
e | thomas.lynch@tballiance.org

Jobs

View job openings

Join our mailing list
Interests
© 2023 The TB Alliance. All Rights Reserved. Site by Darby Communications Report a Concern